3370 results for «2024»
3370 results
Meet up in the cosy PCR Companions Corner at #PCRLV
07 Nov 2025
Kick-off on 16 November at 08:30 with a fun Welcome Breakfast and live music - in a typically British atmosphere!
RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis
01 Sep 2024
While Chiara De Biase interviews Helene Eltchaninoff about the RHEIA trial results, which she presented at the ESC Congress 2024 in London, Panos Xaplanteris shares his perspective on the trial, offering all the essential information and key takeaways you need for your practice!
Author
Author
Author
How to manage conduction disturbances after tricuspid valve interventions?
20 Mar 2025 – From PCR London Valves 2024
Interested in how to manage conduction disturbances after tricuspid valve interventions? Rodrigo Estevez-Loureiro and Marianna Adamo explore the mechanisms behind this common complication, discuss potential predictors and provide practical strategies for management during and after the procedure
This interview was filmed at PCR London Valves 2024: see...
Asymptomatic severe aortic stenosis, how will new evidence change our practice?
15 May 2024 – From EuroPCR 2024
Victoria Delgado and Martin Leon discuss how to treat patients with asymptomatic severe aortic stenosis at an earlier stage and how current trials may change our practice in the future and broaden the indications.
This interview was filmed at EuroPCR 2024: see more videos here.
Three tailored devices to ease the complex PCI procedures
14 May 2024 – From EuroPCR 2024
At EuroPCR 2024, a round table featuring Jianfang Luo, Benjamin Faurie, and Sevket Gorgulu addresses the challenge of streamlining complex PCI procedures. The discussion focuses on three innovative devices: Expressman™, a guiding extension catheter renowned for its one-piece design and side holes, ensuring adequate antegrade blood...
NOTION-2: first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis
15 May 2024 – From EuroPCR 2024
Christopher Cook interviews Ole de Backer about this study he presented at EuroPCR 2024: It provides further data concerning the 1-year outcome of younger AS patients with tricuspid valve anatomy treated with TAVI compared to SAVR. TAVI and SAVR showed similar rates of the primary endpoint...
Focus on PCR Innovators Day
18 Jun 2024 – From EuroPCR 2024
Nicole Karam and Nicolo Piazza highlighted EuroPCR 2024's PCR Innovators Day, which gathered over 400 physicians, ventures, industry partners, and investors to exchange ideas and network. Key topics included valve disease, heart failure, denervation, and the obstacles to innovation across different geographies, addressed in the innovator...
How will the SMART trial results impact our practice and decision making in TAVI?
16 May 2024 – From EuroPCR 2024
Sabine Bleiziffer and Didier Tchétché discuss the SMART trial with Flavio Ribichini in this #europcr 2024 roundtable. The trial compares the self-expandable supra-annular EVOLUT platform and the balloon-expandable intra-annular SAPIEN platform in patients with small aortic annulus, prevalent in up to 40% of Europeans, mainly women....
Strengthening cardiovascular care resilience for healthier hearts: the RESIL-Card project
15 May 2024 – From EuroPCR 2024
In this interview at EuroPCR 2024, William Wijns, Niek Klazinga, and Christopher Cook discuss the RESIL-Card initiative, which emerged from the disruption to cardiovascular care during COVID-19. The initiative aims to use this experience to develop a readiness test for future crises. Extensive data has been collected,...
Learning from the Masters - Key learnings from 20 years of transcatheter edge-to-edge repair
15 May 2024 – From EuroPCR 2024
Maurizio Taramasso interviews Ottavio Alfieri, a pioneering figure in valve surgery and a key contributor to the development of transcatheter edge-to-edge repair, honored with the Ethica Award at the 2024 edition of #europcr. Ottavio Alfieri discusses his journey to becoming a cardiac surgeon, the genesis of...
IVORY FINALE study: Low-dose interleukin-2 for the reduction of vascular inflammation in ACS - Clinical outcomes and follow-up
31 Aug 2024
Aaysha Cader interviews Rouchelle Sriranjan about the results of the IVORY and IVORY 2 trials which she presented at the ESC Congress 2024 in London.
The trials examined low-dose interleukin-2 therapy to reduce arterial inflammation in acute coronary syndrome patients. The study found a 7.7% reduction in arterial inflammation...
Author
Author
Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair
29 Apr 2025 – From PCR London Valves 2024
Curious about the latest advancements in transcatheter tricuspid valve interventions? Don't miss this discussion between Philipp Lurz and Lukas Stolz as they delve into the topic of residual tricuspid regurgitation after transcatheter repair—a challenge that still needs improvement despite significant progress.
This interview was filmed at PCR...
Artificial intelligence (AI) in interventional cardiology
16 May 2024 – From EuroPCR 2024
Watch this discussion with Jan McCloud, Bram Van Ginneken, Niels Van Royen, and Richard Rapoza as they distinguish between artificial intelligence (AI) and machine learning, explore AI's impact on interventional cardiology, and Abbott's integration of AI. They also delve into AI's challenges, including algorithm development complexities...
EARTH-STEMI - Complete vs. culprit-only revascularisation in older STEMI patients
03 Sep 2024
Aaysha Cader interviews Gianluca Campo about the EARTH-STEMI trial he presented at ESC Congress 2024 in London.
This meta-analysis aimed to evaluate a large cohort of STEMI patients, predominantly comorbid, with a mean age of 79 and extended long-term follow-up. The key findings revealed that complete revascularisation reduced the...
Author
Author
How can multi modality imaging contribute to the assessment of multivalve disease?
25 Nov 2024 – From PCR London Valves 2024
Interested in how multi-modality imaging aids in evaluating? Joao Cavalcante and Madalina Garbi explore the challenges of relying solely on echocardiography for diagnosing multivalve disease and explain how techniques like CT and MRI improve the accuracy of assessing valve severity, heart chamber remodeling and support decision-making...
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
Empowering European Healthcare Systems: RESIL-Card, an EU4Health Project, Launches to Enhance Cardiovascular Care Resilience
19 Jan 2024
Paris, 18 January 2024: The consortium and supporting partners that make up the RESIL-Card project kick-started the venture on 1st December 2023.
The 3-year project received a funding grant from the European Commission under the EU4Health Work Programme to strengthen European healthcare systems in providing continuity of care for...
MitraClip sets a new standard for TEER therapy based on the EXPAND G4 data in Japan
20 Mar 2024 – From PCR Tokyo Valves 2024
This video discusses the results of the Expand G4 trial conducted in Japan, focusing on the use of MitraClip for transcatheter edge-to-edge repair therapy. Interviewed by Mike Saji, Masahiko Asami presents data showing a high success rate in Japanese patients, with significant reductions in mitral regurgitation...
Acute coronary syndromes: summary of the 2023 ESC Guidelines - a new chapter in The PCR Textbook
18 Jun 2024 – From EuroPCR 2024
Join Piera Capranzano and Robert Byrne in this video to delve into the new chapter of The PCR Textbook on the 2023 ESC guidelines for acute coronary syndromes. This chapter highlights key points for interventional cardiologists, focusing on invasive management, antiplatelet and anti-thrombotic therapy, and revascularization...
Focus on EAPCI PCR Fellows Course
18 Jun 2024 – From EuroPCR 2024
In celebration of the tenth anniversary of the EAPCI PCR Fellows Course, Gabor Toth interviews Chiara De Biase about the initial target participants of the Course, the topics covered during this one-day event, and the decision to exclude structural topics to promote the PCR London Valves...
